Axsome Therapeutics Inc
NASDAQ:AXSM
Intrinsic Value
The intrinsic value of one
AXSM
stock under the Base Case scenario is
131.65
USD.
Compared to the current market price of 139.58 USD,
Axsome Therapeutics Inc
is
Overvalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Axsome Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Axsome Therapeutics Inc
Balance Sheet Decomposition
Axsome Therapeutics Inc
| Current Assets | 565.3m |
| Cash & Short-Term Investments | 325.3m |
| Receivables | 196.5m |
| Other Current Assets | 43.6m |
| Non-Current Assets | 103.9m |
| PP&E | 22.3m |
| Intangibles | 54.2m |
| Other Non-Current Assets | 27.5m |
Free Cash Flow Analysis
Axsome Therapeutics Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Axsome Therapeutics Inc
|
Revenue
|
561.3m
USD
|
|
Cost of Revenue
|
-45.7m
USD
|
|
Gross Profit
|
515.6m
USD
|
|
Operating Expenses
|
-730.3m
USD
|
|
Operating Income
|
-214.7m
USD
|
|
Other Expenses
|
-14.8m
USD
|
|
Net Income
|
-229.5m
USD
|
AXSM Profitability Score
Profitability Due Diligence
Axsome Therapeutics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Axsome Therapeutics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
AXSM Solvency Score
Solvency Due Diligence
Axsome Therapeutics Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Axsome Therapeutics Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AXSM Price Targets Summary
Axsome Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
AXSM
is 180.65 USD
with a low forecast of 149.48 USD and a high forecast of 210 USD.
Dividends
Current shareholder yield for
AXSM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AXSM
stock under the Base Case scenario is
131.65
USD.
Compared to the current market price of 139.58 USD,
Axsome Therapeutics Inc
is
Overvalued by 6%.